The covid-19 pandemic has highlighted the weaknesses of the health system, given a final boost to existing technologies and increased society's confidence in new treatments and technology. Many of the biggest changes are undoubtedly here to stay. Many pharmaceutical and medical device companies are already showing that they are ready to develop and establish these changes for the long term. It, however, remains to be seen to what extent the legislator and social insurance support these steps, will they enable change or discourage it.
On 6 May 2022 we will be discussing these challenges, trends and opportunities in three panels including LSPG members.
FOR 6 May 2022 here
Please register for the online event until 5 May 2022.